Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Atai Life Sciences N.V. (NQ: ATAI )

5.680 USD +0.100 (+1.79%)
Streaming Delayed Price Updated: 2:56 PM EST, Jan 20, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Atai Life Sciences N.V.

< Previous 1 2 3 4 Next >
Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 14.94% at $0.25 ATAI Life Sciences (NASDAQ:ATAI) shares closed up 3.53% at ... 
Tags FTRP CYBN ALID
From Benzinga
Psilocybin and MDMA Get the Green Light for Medical Use in Canada
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Psychedelic Stock Gainers And Losers From January 18, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 1.90% at $1.07 Intelgenx Technologies (OTC:IGXT) shares closed up 1.41% at ... 
Tags MNMD TRIP GHRS
From Benzinga
Psyched: Delix Raises $30M, New Ketamine Study For Alcohol Use Disorder, FDA Approves Ketamine Trial For ALS
New Awakn Study Shows Ketamine Has Potential To Treat Alcoholism Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) published ... 
Tags Penny Stocks General Small Business
From Benzinga
Psychedelic Stock Gainers And Losers From January 17, 2022
GAINERS: Allied (OTC:ALID) shares closed up 16.57% at $2.11 Filament Health (OTC:FLHLF) shares closed up 11.49% at $0.30 GH Research ... 
Tags CMPS SEEL Cannabis
From Benzinga
The Daily Biotech Pulse: Biogen Slumps As CMS Announces Restrictive Coverage For Aduhelm, Aclaris CMO Departs, Immuron Spikes On US Military Award
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Biogen Shares Slip On ... 
Tags OCGN Guidance IBB
From Benzinga
A Recap of How Psychedelics Fared in 2021
From InvestorBrandNetwork
Why Jim Cramer Likes Illumina And Enterprise Products Partners
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Illumina, Inc. (NASDAQ: ILMN) has got "unbelievable ... 
Tags Jim Cramer Long Ideas CNBC
From Benzinga
Year-End Summary: Marijuana & Psychedelic Compounds-Based Drug Stocks Index Went DOWN -33.6% In 2021!
Which index performed the best in 2021, the Marijuana Drug Stocks Index, or the Psychedelic Compounds-Based Drug Stocks Index? Which constituents contributed to their performances? This article has the... 
Tags Market News
From TalkMarkets
2021 Was The Year Psychedelics Conquered Capitalism...Or Is It The Other Way Around?
Witnessing an entirely new industry being created from scratch is a rare and historic event, one that brings with it tremendous ... 
Tags psychedelics PSY PSIL
From Benzinga
Analysts Anticipate KOMP Will Reach $80
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Steep Decline In Cannabis & Psychedelic Compounds-Based Drug Stocks Continues: DOWN -16.6% MTD
All 12 constituents in the Marijuana & Psychedelic Compounds-Based Drug Stocks Index continue to decline. How do their performances compare month-to-date and YTD? 
Tags Pharma/Biotech Market News Stocks / Equities
From TalkMarkets
The Year In Review For Psychedelic Drug Stocks: 2021
2021 was two different "years" for the psychedelic drug industry. Impressive progress in drug R&D and clinics; stocks pushed down to absurdly lean multiples. 
Tags Pharma/Biotech Market News Stocks / Equities
From TalkMarkets
Mobile Clinics Featuring Novel Mental Health Treatments Reportedly Coming to Florida and Nevada
Photo by Insung Yoon on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house ... 
Tags ATAI News Market News
From Benzinga
46 Biggest Movers From Yesterday
Gainers Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) gained 34.1% to settle at $12.58 on Wednesday. CMC Materials, Inc. ... 
Tags TRT Information Technology ASPU
From Benzinga
36 Stocks Moving In Wednesday's Mid-Day Session
Gainers Nxt-ID, Inc. (NASDAQ: NXTD) shares gained 28.9% to $3.21 after the company said it was awarded U.S. General Services ... 
Tags Top Gainers ASPU LLY
From Benzinga
Dow Down Triple Digits as Fed Meeting Wraps Up
Stocks have deepened their morning losses by midday, with the Dow Jones Industrial Average down 119 points, while both the Nasdaq Composite and S&P 500 Index are firmly in the red as well. 
Tags Market News Stocks / Equities
From TalkMarkets
Mid-Morning Market Update: Markets Open Lower; US Retail Sales Miss Estimates
Following the market opening Wednesday, the Dow traded down 0.26% to 35,453.17 while the NASDAQ fell 0.62% to 15,142.70. The S&P ... 
Tags PSA Mid/Morning Market Update CCMP
From Benzinga
North American Psychedelic Drugs Market Expected To Reach A Value Of $3.184 Billion In 2026
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Entheon Biomedical Reports Launching Multiple Studies to Advance Psychedelic-Based Mental Health Treatments
Image provided by Flickr The following post was written and/or published as a collaboration between Benzinga’s in-house ... 
Tags Partner Content Entheon Biomedical ATAI
From Benzinga
Trip to Sustainability? This Company Is Developing Synthetic Psychedelics To Attempt to Fight Mental Illness
Photo by Raimond Klavins on Unsplash The following post was written and/or published as a collaboration between Benzinga’s ... 
Tags Market News ATAI Markets
From Benzinga
Cannabis & Psychedelic Compound-Based Drug Stocks Continue To Decline
The six marijuana-based clinical-stage stocks are down 31.1% since the end of June; the 9 psychedelic compound-based clinical-stage stocks with market caps under $1B are down 36.3% in that same... 
Tags Market News Stocks / Equities Pharma/Biotech
From TalkMarkets
Psilera's DMT-Derived Drug Sees Positive Results in Pre-Clinical Study
Psilerais a Florida-based biotechnology company focused on developing drugs to treat mental disorders using non-hallucinogenic ... 
Tags CYBN Cannabis Small Cap
From Benzinga
National Institute on Drug Abuse Will Test Ibogaine For Addiction Treatment As Drug Deaths Crest 100,000
The U.S. government has taken a significant step toward tackling the mounting national substance addiction crisis bypartnering ... 
Tags Small Cap Benzinga Regulations
From Benzinga
This Company Is Making Synthetic Psychedelics With a Goal To Combat Mental Illness
Photo by Michael Longmire on Unsplash The following post was written and/or published as a collaboration between Benzinga’s ... 
Tags ATAI Market News Markets
From Benzinga
Atai Life Sciences (NASDAQ: ATAI) Increases Stake in Psychedelic Start-Up Compass Pathways
From InvestorBrandNetwork
New York's Horizons Psychedelic Conference Highlights Big Donations In The Growing Industry
Venture capitalistand businessmanStephen Jurvetsonis joiningan expanding group of prominent investors who are ... 
Tags Cannabis Startups TSLA
From Benzinga
Both Marijuana & Psychedelic Compounds-Based Drug Stocks Indexes Declined Sharply In November
A look at which critical stage drug stock category performed best in November and which constituents contributed to that performance. 
Tags Market News Stocks / Equities Consumer Goods
From TalkMarkets
Analyst Ratings For ATAI Life Sciences
Over the past 3 months, 6 analysts have published their opinion on ATAI Life Sciences (NASDAQ:ATAI) stock. These analysts are typically ... 
Tags ATAI Analyst Ratings Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 30, 2021
Upgrades Sidoti & Co. upgraded the previous rating for DMC Global Inc (NASDAQ:BOOM) from Neutral to Buy. In the ... 
Tags ANNX GDP SPIR
From Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.